Table 2. Mean and S.D. of meloxicam pharmacokinetic parameters after IV administration at 0.5 mg/kg in 6 buffalo calves.
Parameters | Unit | Mean | S.D. |
---|---|---|---|
AUC (0→∞) | h* μg/mL | 118.81 | 27.57 |
t ½ K10 | h | 6.93 | 3.66 |
t ½ α | h | 0.09* | 0.06 |
t ½ β | h | 21.51* | 6.4 |
K10 | 1/h | 0.13 | 0.09 |
K12 | 1/h | 4.18 | 2.89 |
K21 | 1/h | 1.75 | 1.61 |
C0 | μg/mL | 14.39 | 7.13 |
V1 | mL/kg | 40.51 | 15.16 |
ClB | mL/h/kg | 4.38 | 0.95 |
AUMC(0→∞) | h*h* μg/mL | 3991.78 | 1859.87 |
MRT(0→∞) | h | 32.89 | 10.33 |
Vdss | mL/kg | 142.31 | 55.08 |
V2 | mL/kg | 101.8 | 67.31 |
Vz | mL/kg | 146.16 | 53.98 |
AUC (0-∞) = area under serum concentration-time curve from 0 extrapolated to infinity; t ½ K10 = the half-life associated with the rate constant K10; t ½α = distribution half-life; t ½β = elimination half-life; K10 = the rate at which the drug leaves the system from the central compartment (the elimination rate); K12 = the rate at which the drug passes from central to peripheral compartment; K21 = the rate at which the drug passes from peripheral to central compartment; C0 = serum concentration at time 0; V1 = volume of distribution in the central compartment; ClB = body clearance; AUMC = area under moment curve; MRT = mean residence time; Vdss = volume of distribution at steady-state; curve; V2 = volume of distribution in the peripheral compartment; Vz = volume of distribution based on the terminal phase;
* = harmonic mean ± pseudo-deviation standard.